JR
LFCR icon

John Rogers’s Lifecore Biomedical LFCR Stock Holding History

John Rogers’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-322,595
Closed -$4.81M – 155
2018
Q2 		$4.81M Sell
322,595
-18,262
-5% -$254K 0.05% 143
2018
Q1 		$4.45M Sell
340,857
-28,376
-8% -$373K 0.05% 145
2017
Q4 		$4.65M Sell
369,233
-8,012
-2% -$101K 0.05% 147
2017
Q3 		$4.88M Sell
377,245
-140,392
-27% -$1.85M 0.06% 148
2017
Q2 		$7.69M Sell
517,637
-153,941
-23% -$2.14M 0.09% 119
2017
Q1 		$8.06M Sell
671,578
-123,356
-16% -$1.56M 0.09% 123
2016
Q4 		$11M Sell
794,934
-365,652
-32% -$5.07M 0.13% 111
2016
Q3 		$15.6M Sell
1,160,586
-430,238
-27% -$5.21M 0.19% 95
2016
Q2 		$17.1M Sell
1,590,824
-30,710
-2% -$339K 0.21% 90
2016
Q1 		$17M Buy
1,621,534
+305,007
+23% +$3.35M 0.21% 93
2015
Q4 		$15.6M Sell
1,316,527
-103,309
-7% -$1.27M 0.19% 92
2015
Q3 		$16.6M Sell
1,419,836
-22,035
-2% -$292K 0.21% 94
2015
Q2 		$20.8M Sell
1,441,871
-340,793
-19% -$4.92M 0.23% 90
2015
Q1 		$24.9M Buy
1,782,664
+1,236
+0.1% +$17.1K 0.28% 79
2014
Q4 		$24.6M Sell
1,781,428
-28,128
-2% -$363K 0.28% 79
2014
Q3 		$22.2M Sell
1,809,556
-595,571
-25% -$7.43M 0.29% 75
2014
Q2 		$30M Sell
2,405,127
-1,775
-0.1% -$20.9K 0.37% 71
2014
Q1 		$26.9M Buy
2,406,902
+349,180
+17% +$3.83M 0.33% 73
2013
Q4 		$24.9M Buy
2,057,722
+1,078,147
+110% +$12.9M 0.31% 72
2013
Q3 		$12M Buy
979,575
+381,076
+64% +$5.32M 0.17% 85
2013
Q2 		$7.91M Buy
+598,499
New +$8.28M 0.13% 93

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

John Rogers's LFCR Position: Q3 2018 in Review

John Rogers sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 322,595 shares — an estimated $4.81M sold.

John Rogers first reported a position in LFCR in Q2 2013 and held it in 21 quarters. The position peaked at $30M in Q2 2014. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.

  • John Rogers reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
  • John Rogers sold 322,595 Lifecore Biomedical shares in Q3 2018, an estimated $4.81M.
  • John Rogers first reported a position in Lifecore Biomedical in Q2 2013 and held it in 21 quarters.
  • John Rogers's Lifecore Biomedical position peaked at $30M in Q2 2014.
  • 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.

Based on Ariel Investments's 13F filing for Q3 2018, filed 14 Nov 2018.